Trial Profile
A Randomized Open Label Mechanistic Study in Atopic Dermatitis to Assess the Immunogenicity of Fluzone Intradermal and Intramuscular Vaccines
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 23 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 10 May 2013 Planned end date changed from 1 Mar 2013 to 1 May 2013 as reported by ClinicalTrials.gov record.